This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

273 result(s)

Pollen season is highly heterogenous in Southern European countries

01-03-2020
European Academy of Allergy and Clinical Immunology criteria for pollen season may include many intermittent days with low pollen concentrations.

Occupational rhinitis

01-03-2020
Diagnostic approach and the role of nasal provocation tests.

Nasal nitric oxide in children with asthma and allergic rhinitis

01-03-2020
The study compares nasal nitric oxide levels in upper airways in children with respiratory diseases.

Ellipta inhaler

27-11-2015
Ellipta inhaler information for UK healthcare professionals including getting started, how to use the Ellipta inhaler and top tips for your patients.

Sitemap

GlaxoSmithKline (GSK) UK healthcare professional website site map.

GSK support for healthcare professionals in response to COVID-19

Information for healthcare professionals on GSK’s response to COVID-19, where to find support and relevant resources.

DECTOVA▼

Zanamivir IV</br> Influenza

Requip & Adartrel (Ropinirole) artwork change | GSKpro

Information for changes to the colour of the ink on both the cartons and blister packs of Requip and a blister pack of Adartrel.

Supply

Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability

Falsified Medicines Directive

Information to support UK healthcare professionals on the falsified medicines directive in relation to GSK medicines and vaccines.

Homepage

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Therapy areas

GSK UK therapy areas page allows healthcare professionals to find GSK product information by therapy area.

COPD Exacerbations

COPD treatment information to support UK healthcare professionals

COPD expert perspectives

Watch GSK Global Medical Experts approach key issues in COPD treatment, offering solutions for UK healthcare professionals.

COPD triple therapy

COPD treatment information to support UK healthcare professionals

Medicines management and optimisation

Access bespoke financial and prescribing data for your health economy. Identify variability, track and optimise your implementation projects

Respiratory

Overview of Asthma and COPD

Asthma

Overview of Asthma

Severe Asthma

Overview of severe asthma

Ellipta critical error studies in asthma

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their asthma patients

Ellipta critical error studies in COPD

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients

Oncology Expert Insights

Expert opinion on ovarian cancer treatment to support UK healthcare professionals

Vaccines

GSK UK information about our vaccines and disease awareness campaigns

Ordering and delivery

Find out how to set up an account and start ordering GSK vaccines.

Contact us

GSK UK contact page for healthcare professionals

Request a contact

Contact us form for UK healthcare professionals to contact GSK

Report Adverse Event

Form for UK healthcare professionals to report an adverse event related to a GSK product

Educational Resources

Educational resources for health professionals about Allergic Rhinitis

device

Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video

device

Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video

guidelines

Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children

Avamys Overview

Avamys topic index: request, indications, patients, device, efficacy, action, guidelines

safety

Avamys safety in adults and children: well-tolerated, common AE, bioavailability, rapid clearance, no mucosal atrophy, no effect on lower leg growth rate

management-of-AR

Avamys Videos: Avamys device, patient preference study, AR management, efficacy

videos

Avamys Videos: Avamys device, patient preference study, AR management, efficacy

efficacy

Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video

indication

Avamys indications: adult patients with moderate-to-severe perennial AR, seasonal AR, and moderate AR with asthma; pediatric patient

Avamys (fluticasone furoate) - Guidelines

Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children

Avamys (fluticasone furoate) Overview

Avamys (fluticasone furoate) topic index: request, indications, patients, device, efficacy, action, guidelines

Avamys (fluticasone furoate) - safety

Avamys (fluticasone furoate) - safety information in adults and children

management-of-AR

Avamys Videos: Avamys device, patient preference study, AR management, efficacy

Avamys (fluticasone furoate) - videos

Avamys videos: differential diagnosis and management

efficacy

Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video

Avamys (fluticasone furoate) - indication

Avamys (fluticasone furoate) is indicated for the treatment of the symptoms of allergic rhinitis in adults, adolescents and children (6 years and over).

device

Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video

guidelines

Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children

Avamys Overview

Avamys topic index: request, indications, patients, device, efficacy, action, guidelines

safety

Avamys safety in adults and children: well-tolerated, common AE, bioavailability, rapid clearance, no mucosal atrophy, no effect on lower leg growth rate

management-of-AR

Avamys Videos: Avamys device, patient preference study, AR management, efficacy

videos

Avamys Videos: Avamys device, patient preference study, AR management, efficacy

efficacy

Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video

indication

Avamys indications: adult patients with moderate-to-severe perennial AR, seasonal AR, and moderate AR with asthma; pediatric patient

Products

GSK product information for UK healthcare professionals

Varilrix

Varilrix – Chickenpox/varicella vaccine product information to support UK healthcare professionals

Mode of action

Bexsero Meningitis B vaccine mode of action information for UK healthcare professionals

Invasive Meningococcal Disease

Bexsero Meningitis B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD)

Epidemiology

Bexsero Men B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD) epidemiology

Transmission and symptoms

Bexsero Meningitis B vaccine transmission and symptoms information for UK healthcare professionals

Bexsero

Bexsero Meningitis B vaccine information for UK healthcare professionals

Bexsero Overview

Bexsero Meningitis B vaccine overview for UK healthcare professionals

Seretide inhaler technique and safety

Videos and materials to help you ensure your patients are using their Seretide Accuhaler and Evohaler correctly.

Adartrel

Adartrel (ropinirole hydrochloride) - links to the summary of product characteristics, patient information leaflet and supply information to support UK healthcare professionals.

Duac (clindamycin / benzoyl peroxide) Prescribing Information | GSKpro

An overview of Duac formulation, strengths, indication and how to prescribe.

Duac (clindamycin / benzoyl peroxide) - Resources | GSKpro

Duac materials (leaflets) to support UK healthcare professionals

Duac (clindamycin / benzoyl peroxide) - EDF guideline | GSKpro

An overview of the EDF guideline recommendations for the treatment.

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) - Why Duac? | GSKpro

Why to choose Duac supporting information.

Duac (clindamycin / benzoyl peroxide) vs Zineryt | GSKpro

Duac with erythromycin/zinc (Zineryt) comparison.

Duac (clindamycin / benzoyl peroxide) mode of action | GSKpro

Duac information about mode of action and antibiotic resistance

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac information to support UK healthcare professionals

Duac (clindamycin / benzoyl peroxide) - Heritage & Efficacy | GSKpro

An overview of GSK Heritage. Duac helping patients for over 15 years.

Duac (clindamycin / benzoyl peroxide) - complications video | GSKpro

Video about meeting the challenges of complications.

Duac (clindamycin / benzoyl peroxide) Videos | GSKpro

Duac Videos to support UK healthcare professionals.

Duac (clindamycin phosphate/benzoyl peroxide) - infographics for healthcare professionals

Duac - information for healthcare professionals on the treatment (infographics)

Duac (clindamycin / benzoyl peroxide) - e-modules | GSKpro

E-modules to support UK healthcare professionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Trelegy▼ Ellipta

Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) product information & resources to support UK healthcare professionals in their daily practice.

Efficacy and safety

Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) efficacy and safety information to support UK healthcare professionals.

Quality of Life (IMPACT)

Health-related QoL efficacy results for TRELEGY Ellipta

Efficacy

Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.

Lung Function (IMPACT)

Lung Function efficacy results for TRELEGY Ellipta

Exacerbations (IMPACT)

Exacerbation efficacy results for TRELEGY Ellipta.

Video Testimonials: I've Seen Meningitis

Video testimonials from healthcare professionals about the impact of meningitis

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

Show more